Abstract
Introduction
The vascularization of large three-dimensional constructs is a major challenge in tissue engineering [1] [2] [3] . Thus far, experimental modulation of angiogenic processes in tissue-engineered three-dimensional matrices has mainly been attempted through delivery of angiogenic growth factors as recombinant proteins or by gene transfer [4, 5] [6] [7] [8] and may also be used to induce blood vessel formation in tissue-engineered matrices, which could then be used to pre-fabricate organs or tissues for regenerative purposes [9] . [10, 11] . Similarly, intravenous infusion of exogenous EPC after ischaemic injury results in their homing to ischaemic areas [8, 12] where they have been shown to directly contribute to blood vessel formation and increase overall density of blood vessels. The latter observation implies support of local angiogenesis by EPC in a paracrine manner, i.e. via secretion of proangiogenic factors including VEGF [12] , which is known to be one of the most potent angioinductive growth factors. Even though delivery of VEGF both as a recombinant protein and via gene transfer has a certain angiogenic potential [13, 14] , the number of local endothelial cells that can be stimulated by angioinductive molecules such as VEGF is limited [15] . Alternatively [16, 17] [16, 18] . T17b EPC are also a source of a multitude of secreted proteins that modulate angiogenesis and tissue regeneration [8] . (Fig. 1A, left panel) Fig. 3A) . No VEGF expression was detected in cell-free matrices, which served as negative controls (Fig. 3A, right panel) . RNA yield generated from BM matrices, on the other hand, was 4 times higher compared to DM matrices (0.444 Ϯ 0.028 µg versus 0.112 µg Ϯ 0.012, P Ͻ 0.05, Fig. 3B ), indicating the number of cells present in DM matrices was significantly higher.
. Endothelial progenitor cells (EPC) have been shown to enhance vascularization in various pathological conditions of tissue ischaemia such as myocardial infarction and peripheral vascular disease

Thus far, there is little knowledge on how EPC may support vascularization of these bioartificial constructs. There appear to be, however, several mechanisms by which EPC exert their therapeutic pro-angiogenic effects in animal models or humans. Upon vascular trauma, cytokines and growth factors such as granulocyte monocyte-colony stimulating factor (GM-CSF) and
T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix
. Differentiation or activation of EPC was accompanied by induction of von Willebrand Factor (vWF) and VEGF receptor 2 (VEGFR-2) among other genes
Materials and methods
Cell culture
T17b morphology in 3-D fibrin matrix cultures
In the fibrin matrix, morphology and growth properties of T17 EPC were observed and their proliferation was quantified by immunohistochemical analysis of Ki-67. Upon differentiation with dibutyrylcAMP and RA, EPC proliferation appeared to be inhibited with low cell numbers and little cluster formation. These findings were confirmed by the lack of Ki-67 positive T17b cells (Fig. 4A-C) Fig. 4D-F) . (Fig. 5A) . Similar differences were noticed when the number of cell clusters was counted, again reaching statistically significant differences on day 8 (Fig. 5B) . (Fig. 6 ). [8, 12, [16] [17] [18] . A significant advantage over human EPC can be attributed to the fact that they can be transplanted xenogenically into immunocompetent recipients such as rats and rabbits [8] , whereas the use of human EPC in vivo is restricted to immunodeficient animals such as nude mice. Due to size limitation of the animal, many surgical in vivo models of angiogenesis including the arteriovenous (AV) loop model in the rat for tissue engineering [27] are not applicable to a murine model, thus restricting attempts to generate larger units of vascularized bioartificial tissue in vivo.
For semi-quantitative assessment of growth patterns, cells and cell clusters were counted in 5 randomly selected areas per slide per study group. DM leads to a reduction in cell number and cell clusters (Fig. 5A) from day 3 to day 8 (60 cells/ROI versus 46 cells/ROI, P Ͻ 0.05). On the other hand, BM incubation resulted in higher numbers of cells and cell clusters at both times and an increase of cell numbers and number of cell clusters (131 cell/ROI versus 166 cell/ROI, P Ͻ 0.05). The difference in cell numbers on day 8 between BM and DM groups was considered statistically significant
Fig. 1 Hypoxia stimulates VEGF and vWF secretion from T17b EPC in 2-D cultures (A)
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(A-C) DM incubation in 100ϫ (A) and 400ϫ (B) magnification and Ki-67 expression (C). Upon differentiation with dibutyryl-cAMP and retinoic acid, EPC proliferation appeared to be inhibited with low cell numbers and little cluster formation. These findings were confirmed by the lack of Ki-67 positive T17b cells. (D-F) BM incubation in 100ϫ (A) and 400ϫ (B) magnification and Ki-67 expression (C). In contrary, after incubation with basal medium, morphologic observation showed cell proliferation and growth in clusters, some of them forming lumen-like structures. Morphologic observations were endorsed by the presence of Ki-67-positive cells, indicating cell proliferation up to the end of the observation period on day 8.
T17b PCR in 3-D cultures
In order to investigate differentiation of T17b EPC in fibrin matrices, expression of the differentiation markers vWF and VEGFR-2 was analysed with PCR. In conformance with previously published results for 2-D cell cultures [16], we detected increased expression of vWF as well as VEGFR-2 after differentiation compared to undifferentiated controls
Discussion
In the present study, we investigated T17b murine embryonal EPC in terms of morphology, proliferative potential and VEGF secretion in response to hypoxia and differentiation in vitro in cell culture and a clinically approved fibrin matrix culture.
Hypoxia can stimulate VEGF secretion as well as vWF expression and cell proliferation in 2-D culture
VEGF is an important angiogenic factor in blood vessel formation and plays a key role in the angiogenic function of EPC [20] . Since previous studies showed co-localization of T17b EPC and VEGF expression preferentially in areas of tissue hypoxia [12] 
